more official website M A D E R OxX®

Testings on persons of the age between 20 and 80 years showed the following results

lowered stress feelings and a noticeable increased well-being
blood pressure and pulse were mostly lower or properly after the treatment
test-persons with pains noted a pain reduction after the treatment
75% felt the treatment as very soothing and pleasant and 25% as soothing and pleasant
80% felt a deeper and soothing breath
90% felt a risen self-awareness and would definitively recommend the method
75% felt the wooden treatment-device as very pleasant and 25% as pleasant

M A D E R OxX® - A Moderate Pressure Therapy

A large scaled study from the University of Miami Medical School attracted our attention. The study was published in 2014 and informed that moderate pressure therapies – like the M A D E R OxX®-method is offering - has contributed to many positive effects such as increased weight gain in preterm infants, reduced pain caused by different syndromes including fibromyalgia and rheumatoid arthritis, enhanced attentiveness, reduced depression and enhanced immune function (increased natural killer cells and natural killer cell activity). Moderate pressure therapies reduce depression, anxiety and have also led to increased vagal activity, decreased cortisol levels and decreased substance "P". Moderate pressure therapies were represented in several brain regions including the amygdala, the hypothalamus and the anterior cingulate cortex, all areas involved in stress and emotion regulation.

The study evaluation included the "Gate Control Theory". One of the pain therapy approaches on which the M A D E R OxX®-method is also based on. The mechanism that has been mostly used to explain “The Gate Control Theory” is thought to stimulate shorter and less myelinated (insulated) nerve fibers. As a result, the neurotransmitter GABA (gamma-Aminobutyric acid) is produced. This in turn enables the so called "pain gate" to close.

Tests with the therapeutic method of M A D E R OxX® have shown, that subjects who had feelings of pain before the given therapy mostly noted a reduction in pain after the first treatment. Among many other positive feedbacks, test subjects also confirmed, that the breath deepens during treatment and with it a deep relaxation sets in. These are indicators that can naturally increase the GABA level as well.

M A D E R OxX® - For Mental Health
Depression is a common illness worldwide, with more than 264 million people affected. Depressed individuals often have a greater right than left frontal lobe activity. A large scaled US study (published 2014) was able to prove, that after a short moderate pressure massage - just like M A D E R OxX® offers - the frontal lobe activity shifted from right to left. UNHCR’s annual Global Trends Report – released on 19 June 2019 – shows that nearly 70.8 million people were displaced at the end of 2018. The armed conflicts all over the world not only leave mental health problems for the people affected, but is also traumatizing entire generations. As those issues are often left untreated, mental stress associated with war trauma can have serious repercussions on a whole society. M A D E R OxX® test subjects who showed a high level of stress or had mentioned a high level depressed mood confirmed that their well-being improved significantly after the first treatment and that their sense of stress was noticeably reduced.

M A D E R OxX® - Develops the Positive Properties of Touch Without Direct Body Contact
The M A D E R OxX® method stimulates the receptors which absorb stimuli over the skin and through the moderate pressure stimulation the production of Oxytocin in the Hippocampus can be promoted. Oxytocin is a touch hormone which amongst other things reduces fear. Bonn scientists, together with colleagues of the German research center Heidelberg and the University of Chengdu (China), were able to document the anxiolytic effect. M A D E R OxX® test subjects report a noticeably higher level of well-being after the treatment.
(Source: Oxytocin Facilitates the Extinction of Conditioned Fear in Humans”, Biological Psychiatry 2014)